InternshipIntensive training in scientific and venture due diligence for healthcare technology and biotech investments.

RA Capital Management is a multi-stage investment manager based in Boston, Massachusetts, focusing on evidence-based investing in healthcare and life science companies. They provide seed funding to startups and lead financing rounds for established firms.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Third-party rankings
| Ranking | Edition | Position | Since last edition | Trust | What it measures |
|---|---|---|---|---|---|
| 2026 | #2 | Down 1 | A | Activity, Finance |
RA Capital Management, founded in 2004, is a multi-stage investment manager located in Boston, Massachusetts. The firm specializes in evidence-based investing in both public and private healthcare and life science companies that are developing drugs, medical devices, diagnostics, services, and research tools. RA Capital's investment strategy spans various stages, from seed funding to public follow-on financings, allowing them to engage with companies at different development phases. Their portfolio includes notable companies such as Abcuro, Inc. and Adagio Medical. The firm also operates initiatives like TechAtlas for market intelligence and Raven, an in-house incubator for innovative healthcare solutions.
RA Capital invests in healthcare and life science companies, providing funding and support from seed stage to IPO and follow-on financings. Their investment strategy encompasses a wide range of therapeutic areas and stages of development, supported by their research division, TechAtlas, which analyzes scientific and clinical data to inform investment decisions.
RA Capital adds value to its portfolio companies through strategic support, leveraging their expertise in healthcare and life sciences, and utilizing their research division, TechAtlas, to provide data-driven insights that inform decision-making and enhance growth potential.
RA Capital focuses on healthcare and life sciences companies at various stages, from seed to growth equity. They seek innovative solutions in drug development, medical devices, diagnostics, and research tools.
Startups can pitch to RA Capital through their website at racap.com/venture. They recommend including detailed information about the business model, market opportunity, and team in the pitch deck.
RA Capital's evidence-based investing approach, combined with their proprietary research platform, TechAtlas, allows them to make informed investment decisions and provide strategic guidance to portfolio companies.
RA Capital invests globally, with a strong focus on North America and the United States.
RA Capital typically invests between $500,000 and $75 million in their portfolio companies.
From public sources
Rapport provides a newsletter signup with Biotech/Pharma, Planetary Health, and Both interest options; submission opts into marketing communications.
Source: Rapport | RA CapitalRA Capital's official navigation links to RA University, whose Thinkific site offers free registration and listed biotech courses.
Source: RA UniversityRA Capital describes Raven as its company-building platform since 2018.
Source: Raven | RA CapitalRA Capital's official contact page invites company meeting requests at request@racap.com and asks capital-raising companies to include a non-confidential slide deck.
Source: Contact | RA CapitalRA Capital describes itself as a multi-stage investor and company builder across healthcare, life sciences, and planetary health.
Source: About | RA CapitalThe Planetary Health FAQ says emailing request@racap.com is an equally good option to a team connection, and every pitch is routed through the same evaluation process regardless of origin.
Source: Planetary Health | RA CapitalSuperscout Pro
Is this page right?Reviewed · How the research works